APA (7th ed.) Citation

Fager, A., Samuelsson, M., Bagge, R. O., Pivodic, A., Bjursten, S., Levin, M., . . . Ny, L. Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases. Nature Portfolio.

Chicago Style (17th ed.) Citation

Fager, Anna, Matilda Samuelsson, Roger Olofsson Bagge, Aldina Pivodic, Sara Bjursten, Max Levin, Henrik Jespersen, and Lars Ny. Immune Checkpoint Inhibitor Therapy Is Associated with a Decreased Risk of Developing Melanoma Brain Metastases. Nature Portfolio.

MLA (9th ed.) Citation

Fager, Anna, et al. Immune Checkpoint Inhibitor Therapy Is Associated with a Decreased Risk of Developing Melanoma Brain Metastases. Nature Portfolio.